Resverlogix Corp. (TSE:RVX – Get Free Report) shares passed below its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of C$0.06 and traded as low as C$0.05. Resverlogix shares last traded at C$0.06, with a volume of 2,400 shares changing hands.
Resverlogix Stock Up 10.0 %
The firm has a market capitalization of C$15.23 million, a PE ratio of -1.10 and a beta of 0.71. The stock has a 50-day moving average price of C$0.06 and a 200 day moving average price of C$0.06.
Resverlogix (TSE:RVX – Get Free Report) last issued its quarterly earnings results on Tuesday, November 12th. The biotechnology company reported C($0.03) EPS for the quarter. As a group, equities analysts predict that Resverlogix Corp. will post -0.22 earnings per share for the current fiscal year.
About Resverlogix
Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.
Featured Articles
- Five stocks we like better than Resverlogix
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- What Does the Future Hold for Eli Lilly?
- The Risks of Owning Bonds
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for Resverlogix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Resverlogix and related companies with MarketBeat.com's FREE daily email newsletter.
